Benitec Biopharma Inc. (BNTC)
USD 11.84
(-7.28%)
USD 11.84
(-7.28%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -19.4 Million | -18.01 Million | -15.89 Million | -12.83 Million | -7.53 Million | 4.79 Million |
| Net Income | -21.75 Million | -19.56 Million | -18.2 Million | -13.88 Million | -8.27 Million | 2.6 Million |
| Depreciation & Amortization | 343 Thousand | 381 Thousand | 392 Thousand | 424 Thousand | 374 Thousand | 158 Thousand |
| Deferred income taxes | - | -714 Thousand | - | - | - | -957.19 Thousand |
| Stock-based compensation | 830 Thousand | 452 Thousand | 870 Thousand | 634 Thousand | 237 Thousand | 957.19 Thousand |
| Change in working capital | 1.17 Million | 714 Thousand | 1.03 Million | 8000.00 | 126 Thousand | 1.32 Million |
| Other non-cash items | 831 Thousand | 717 Thousand | 10 Thousand | -16 Thousand | 2000.00 | 700 Thousand |
| Investing Cash Flow | -179 Thousand | -1000.00 | -13 Thousand | -221 Thousand | -94 Thousand | -399.19 Thousand |
| Investments in PPE | -179 Thousand | -1000.00 | -13 Thousand | -221 Thousand | -95 Thousand | -403.39 Thousand |
| Acquisitions | - | - | - | - | 1000.00 | 4000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 202.03 |
| Financing Cash Flow | 68.02 Million | 16.01 Million | - | 22.52 Million | 1.77 Million | -688.11 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -619 Thousand | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 73.92 Million | 17.88 Million | - | 25.75 Million | 2.25 Million | - |
| Other Financing Activities | -5.89 Million | -1.86 Million | - | -3.22 Million | -480 Thousand | - |
| Accounts receivables | -176 Thousand | -50 Thousand | 1000.00 | 28 Thousand | 2.39 Million | 607 Thousand |
| Accounts payables | 941 Thousand | 1.35 Million | 1.09 Million | 55 Thousand | -1.69 Million | 740 Thousand |
| Inventory | - | -1.3 Million | -1.09 Million | -83 Thousand | -700 Thousand | - |
| Other working capital | 409 Thousand | 714 Thousand | 1.03 Million | 8000.00 | 126 Thousand | -24 Thousand |
| Cash at beginning of period | 2.49 Million | 4.07 Million | 19.78 Million | 9.8 Million | 15.71 Million | 11.26 Million |
| Cash at end of period | 50.92 Million | 2.49 Million | 4.07 Million | 19.76 Million | 9.8 Million | 15.69 Million |
| Capital Expenditure | -179 Thousand | -1000.00 | -13 Thousand | -221 Thousand | -95 Thousand | -403.39 Thousand |
| Effect of forex changes on cash | -8000.00 | 412 Thousand | 204 Thousand | 499 Thousand | -58 Thousand | 727.65 Thousand |
| Net cash flow / Change in cash | 48.43 Million | -1.58 Million | -15.7 Million | 9.96 Million | -5.91 Million | 4.43 Million |
| Free Cash Flow | -19.58 Million | -18.01 Million | -15.91 Million | -13.05 Million | -7.63 Million | 4.38 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.72 Million | -4.27 Million | -6.79 Million | -5.95 Million | -19.56 Million | -4.66 Million |
| Depreciation & Amortization | 91 Thousand | 90 Thousand | 80 Thousand | 82 Thousand | 381 Thousand | 84 Thousand |
| Deferred income taxes | - | - | - | -1.2 Million | -714 Thousand | - |
| Stock-based compensation | 454 Thousand | 192 Thousand | 93 Thousand | 91 Thousand | 452 Thousand | 127 Thousand |
| Change in working capital | 882 Thousand | -2.16 Million | 1.25 Million | 1.2 Million | 714 Thousand | 356 Thousand |
| Other non-cash items | 379.14 Thousand | 2.59 Million | 1000.00 | 1.2 Million | 717 Thousand | -1000.00 |
| Investing Cash Flow | -565.04 | -179.42 Thousand | - | - | -1000.00 | -1000.00 |
| Investments in PPE | -564.34 | -179.42 Thousand | - | - | -1000.00 | -1000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 40.07 Million | 154.88 Thousand | 39 Thousand | 27.91 Million | 16.01 Million | -264.58 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 42.99 Million | 154.88 Thousand | 39 Thousand | 30.88 Million | 17.88 Million | -264.58 Thousand |
| Other Financing Activities | -2.92 Million | - | 57.22 Thousand | -2.96 Million | -1.86 Million | 17.88 Million |
| Accounts receivables | -176.97 Thousand | - | - | - | -50 Thousand | 826.05 |
| Accounts payables | 1.54 Million | -2.3 Million | 1.13 Million | 566 Thousand | 1.35 Million | 761.95 Thousand |
| Inventory | - | - | - | - | -1.3 Million | -762.78 Thousand |
| Other working capital | -484.85 Thousand | 142.51 Thousand | 123.41 Thousand | 638 Thousand | 714 Thousand | 355.99 Thousand |
| Cash at beginning of period | 14.15 Million | 20.38 Million | 25.87 Million | 2.49 Million | 4.07 Million | 6.56 Million |
| Cash at end of period | 50.92 Million | 14.15 Million | 20.38 Million | 25.87 Million | 2.49 Million | 2.49 Million |
| Capital Expenditure | -564.34 | -179.42 Thousand | - | - | -1000.00 | -1000.00 |
| Effect of forex changes on cash | -5000.00 | 115 Thousand | -163 Thousand | 45 Thousand | 412 Thousand | 21 Thousand |
| Net cash flow / Change in cash | 36.77 Million | -6.23 Million | -5.48 Million | 23.38 Million | -1.58 Million | -4.07 Million |
| Free Cash Flow | -3.29 Million | -6.41 Million | -5.36 Million | -4.57 Million | -18.01 Million | -4.09 Million |
GMNI
NLFL
BCRD
GANDHITUBE
PANAENERG
ELD